|
| Press Releases |
|
 |
|
| Monday, June 23, 2025 |
|
|
Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis |
| Hua Medicine ("the Company", stock code: 2552.HK) announced today that the Company presented the latest research results of dorzagliatin, its global first-in-class glucokinase activator (GKA), at the 85th Scientific Sessions of the American Diabetes Association (ADA). more info >> |
|
|
華領醫藥在2025ADA科學年會公佈多格列艾汀與DPP-4抑制劑聯用在恢復血糖穩態的同時有望降低血脂 |
| 華領醫藥（“公司”，香港聯交所股份代號：2552.HK）今天宣佈，第85屆美國糖尿病協會（ADA）科學年會上，公司展示了其全球首創新藥葡萄糖激酶激活劑（GKA）多格列艾汀（dorzagliatin）的最新研究成果。 more info >> |
|
|
华领医药在2025ADA科学年会公布多格列艾汀与DPP-4抑制剂联用在恢复血糖稳态的同时有望降低血脂 |
| 华领医药（“公司”，香港联交所股份代号：2552.HK）今天宣布，第85届美国糖尿病协会（ADA）科学年会上，公司展示了其全球首创新药葡萄糖激酶激活剂（GKA）多格列艾汀（dorzagliatin）的最新研究成果。 more info >> |
|
| Friday, March 28, 2025 |
|
|
Hua Medicine Announces 2024 Annual Results |
| Hua Medicine ("the Company", Hong Kong Stock Exchange Stock Code: 2552) announced the audited full-year results of the Company and its subsidiaries for the year ended December 31, 2024 (the "Reporting Period"), along with the Company's business progress in 2024 and future business outlook. more info >> |
|
|
華領醫藥公佈2024年全年業績 |
| 華領醫藥（「公司」，香港聯交所股份代號：2552）宣佈公司及其附屬公司截至2024年12月31日止，經審核的全年業績（「報告期」），以及公司2024年業務進展和未來業務展望。華領醫藥在核心產品葡萄糖激酶啟動劑（GKA）多格列艾汀片（商品名：華堂寧(R)）的商業化，以及公司研發創新、產能優化等方面均取得了重要進展，為公司的長期可持續發展奠定了堅實基礎。 more info >> |
|
|
华领医药公布2024年全年业绩 |
| 华领医药（“公司”，香港联交所股份代号：2552）宣布公司及其附属公司截至2024年12月31日止，经审核的全年业绩（“报告期”），以及公司2024年业务进展和未来业务展望。华领医药在核心产品葡萄糖激酶激活剂（GKA）多格列艾汀片（商品名：华堂宁(R)）的商业化，以及公司研发创新、产能优化等方面均取得了重要进展，为公司的长期可持续发展奠定了坚实基础。 more info >> |
|
| Tuesday, March 18, 2025 |
|
|
Dr. Li Chen Honored as A Leading Figure in Shanghai's Industry and Commerce |
| On March 17th, the highly anticipated 7th Commendation and Exchange Conference for the Leading Figures in Shanghai's Industry and Commerce was brought to a successful conclusion. Dr. Li Chen, the founder and CEO of Hua Medicine, was awarded the title of "A Leading Figure in Shanghai's Industry and Commerce" for his outstanding contributions and innovative leadership in the field of biomedicine. more info >> |
|
|
陳力博士當選上海市工商業領軍人物 |
| 3月17日，第七屆上海市工商業領軍人物表彰交流大會順利舉行，華領醫藥創始人、CEO陳力博士憑藉其在生物醫藥領域的卓越貢獻和創新領導力，獲評為「上海市第七屆工商業領軍人物」，並代表獲獎企業家作交流發言。 more info >> |
|
|
陈力博士当选上海市工商业领军人物 |
| 3月17日，第七届上海市工商业领军人物表彰交流大会顺利举行，华领医药创始人、CEO陈力博士凭借其在生物医药领域的卓越贡献和创新领导力，获评为“上海市第七届工商业领军人物”，并代表获奖企业家作交流发言。 more info >> |
|
| Monday, March 3, 2025 |
|
|
Hua Medicine Awarded Shanghai Innovative Enterprise Headquarters |
| On February 27th, the awarding ceremony of the second batch of Shanghai Innovative Enterprise Headquarters was held in Shanghai. Gong Zheng, Deputy Secretary of Shanghai Municipal Party Committee and Mayor of Shanghai, awarded the certificates to 49 innovative enterprise headquarters, and Hua Medicine was among them. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
WRC 2025: Shoucheng Showcases Full Robotics Value Chain
Aug 11, 2025 16:27 HKT/SGT
|
|
|
Intellifusion Submits an Application to List on the Hong Kong Stock Exchange: A National Breakthrough in AI Inference Chips
Aug 11, 2025 16:25 HKT/SGT
|
|
|
Everest Medicines Announces Full Approval of NEFECON(R) in Taiwan
Aug 11, 2025 16:25 HKT/SGT
|
|
|
Campaign to promote Hong Kong's advantages in professional services in Vietnam
Aug 11, 2025 16:03: JST
|
|
|
Campaign to promote Hong Kong's advantages in professional services in Vietnam
Aug 11, 2025 15:03 HKT/SGT
|
|
|
31 Concept to Debut Patent-Pending Technology at ISS Asia 2025 in Singapore
Aug 11, 2025 13:13 HKT/SGT
|
|
|
31 Concept將在2025年新加坡ISS Asia首度發佈其申請專利的新技術
Aug 11, 2025 13:13 HKT/SGT
|
|
|
Qube Celebrates 20 Years of Business Events Impact with Industry Recognition and Vision for the Future
Aug 11, 2025 12:03 HKT/SGT
|
|
|
TransNusa Focuses on Organic Growth to Strengthen Network Connectivity in China
Aug 11, 2025 11:00 HKT/SGT
|
|
|
沙烏地電力公司2025年第二季淨利成長22%
Aug 11, 2025 11:00 HKT/SGT
|
|
|
Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products
Aug 11, 2025 10:41 HKT/SGT
|
|
|
康灃生物中期業績創紀錄 呼吸介入產品驅動收入激增162%
Aug 11, 2025 10:41 HKT/SGT
|
|
|
康沣生物中期业绩创纪录 呼吸介入产品驱动收入激增162%
Aug 11, 2025 10:41 HKT/SGT
|
|
|
Shoucheng-Backed Data Center REITs Surge on Market Debut
Aug 11, 2025 09:00 HKT/SGT
|
|
|
首批數據中心REITs上市首日雙雙漲停 首程控股再顯產業資本實力
Aug 11, 2025 09:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
